miR-148-3p targets DNMT1 (a gene involved in DNA methylation) which regulate adipocyte differentiation and obesity [74] and also targets WNT-1/β-catenin, AKT/ERK, IGF-1R signaling pathways in breast cancer [75]. The gene discussed is AKT1; the disease is breast cancer.